Inhalation Sciences signs exclusive distribution agreement with Apex Inhalation for sales expansion into India, Bangladesh and Sri Lanka
(Stockholm, Sweden, April 22, 2021) ISAB has signed an exclusive distribution agreement with Apex Inhalation, a spinoff of Apex Chromatography, one of South Asia’s leading suppliers of laboratory equipment. The region is one of the world’s largest and fastest-growing inhalation R&D markets with many global pharma companies having large-scale research and manufacturing facilities there. The agreement covers India, Bangladesh and Sri Lanka, and the potential in sales of instruments and services is estimated at over 3 MSEK for the rest of 2021 and 2022.
ISAB has signed an agreement with Apex Inhalation, a new spinoff from Apex Chromatography – one of South Asia’s major laboratory suppliers with offices in Hyderabad and Mumbai, and particularly robust ties with the region’s respiratory and inhalation research labs. Apex Inhalation specializes exclusively on high-end equipment for inhalation labs.
Apex Chromatography is the region’s exclusive supplier of Copley Scientific equipment, one of the world’s leading inhalation R&D equipment companies, with many systems complementary to Inhalation Sciences' instruments.
ISAB COO Paolo Raffaeli: “We are delighted to sign this agreement with such a robust and highly respected partner in the region. Apex’s vast experience, extensive network and outstanding record in supply and service to the region’s extensive inhalation research facilities will be a powerful driver of new sales for us.”
ISAB CEO Manoush Masarrat: “Geographical expansion of our marketing and sales activities is a vital strategy for ISAB under 2021. South Asia is an enormous and high-potential market for us, and we are confident that this new agreement will open up profitable new sales, relationships and long-term commitments in the area as we move forward.”
For more information about Inhalation Sciences, please contact: Manoush Masarrat, CEO E-mail: Manoush.firstname.lastname@example.org Mobile: +46 (0)73 628 9153Press release in PDF format